NAD+ (500 mg Vial)

Complete dosage protocol and reconstitution guide for NAD+ (500 mg Vial). Review reconstitution steps, storage guidance, syringe units, and research-use notes.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
NAD+ (500 mg Vial)

CAT No:

CAS No:

Synonyms/Alias:NAD+

M.F/Formula:

M.W/Mr.:

Purity:Specification by inquiry

Custom Peptide Support
  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

Complete dosage protocol and reconstitution guide for NAD+ (500 mg Vial). Review reconstitution steps, storage guidance, syringe units, and research-use notes.

Quickstart

Reconstitute: Add 3.0 mL bacteriostatic water → 166.7 mg/mL concentration.

Typical daily range: 50–100 mg once daily subcutaneously (gradual titration from lower doses).

Easy measuring: At 166.7 mg/mL, 1 unit = 0.01 mL = 1.67 mg on a U‑100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) for up to 14 days; protect from light and avoid freeze–thaw cycles.

Notes

Practical considerations for consistency, safety, and optimal results. Use new, sterile insulin syringes for each injection; dispose of used needles in a proper sharps container. Rotate injection sites systematically (abdomen at least 2 inches from navel, outer thighs, back of upper arms) to reduce soreness and prevent lipohypertrophy. Clean both the vial stopper and injection site with alcohol swabs; allow skin to air‑dry before injecting. Inject slowly over 5–10 seconds to minimize tissue irritation; wait a few seconds before withdrawing the needle. Document daily dose, injection site, and a

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Source URL
https://peptide.cn.com/single-peptide-dosages/nad-500-mg-10ml-vial-dosage-protocol
Week 1
Daily Dose (mg): 50 mg | Units (per injection) (mL): 30 units (0.30 mL)
Week 2
Daily Dose (mg): 75 mg | Units (per injection) (mL): 45 units (0.45 mL)
Weeks 3–8
Daily Dose (mg): 100 mg | Units (per injection) (mL): 60 units (0.60 mL)
Weeks 9–12
Daily Dose (mg): 100 mg | Units (per injection) (mL): 60 units (0.60 mL)
Weeks 13–16
Daily Dose (mg): 100 mg | Units (per injection) (mL): 60 units (0.60 mL)
Long-term Storage Conditions
Lyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) for up to 14 days; protect from light and avoid freeze–thaw cycles.
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (NAD+, 500 mg each): 8 weeks ≈ 11 vials (total 5,075 mg used)

12 weeks ≈ 16 vials (total 7,875 mg used)

16 weeks ≈ 22 vials (total 10,675 mg used)

Insulin Syringes (U‑100, 1 mL): Per week: 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

16 weeks: 112 syringes

Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution. 8 weeks (11 vials): 33 mL → 4 × 10 mL bottles

12 weeks (16 vials): 48 mL → 5 × 10 mL bottles

16 weeks (22 vials): 66 mL → 7 × 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day. Per week: 14 swabs (2/day)

8 weeks: 112 swabs → recommend 2 × 100‑count boxes

12 weeks: 168 swabs → recommend 2 × 100‑count boxes

16 weeks: 224 swabs → recommend 3 × 100‑count boxes

Product Gallery
Quick Inquiry
Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsApp Mia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China